Meta-Analysis of Randomized Controlled Trials on Androgens versus Erythropoietin for Anaemia of Chronic Kidney Disease: Implications for Developing Countries
Androgens which are relatively cheap were used in the treatment of anaemia in dialysis patients before the advent of Erythropoietin (EPO). However, there are concerns about their efficacy and side effects. Aims. To examine the efficacy and harms of androgens for the treatment of anaemia of chronic k...
Saved in:
Main Authors: | B. Adamu, S. M. Ma'aji, P. J. Erwin, I. M. Tleyjeh |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | International Journal of Nephrology |
Online Access: | http://dx.doi.org/10.1155/2012/580437 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Randomized, Open-Label Phase 2 Study of Apalutamide plus Androgen Deprivation Therapy versus Apalutamide Monotherapy versus Androgen Deprivation Monotherapy in Patients with Biochemically Recurrent Prostate Cancer
by: Rahul Aggarwal, et al.
Published: (2022-01-01) -
Factors Leading To Severe Anaemia In Patients With Chronic Kidney Disease
by: Erum Afaq, et al.
Published: (2024-12-01) -
Erythrocytes and Erythropoietin
by: Michael Föller, et al.
Published: (2011-01-01) -
Recombinant human erythropoietin, and myocardial and cerebral acute ischemia: implications for clinical use.
by: Rafael Alejandro Gómez Baute, et al.
Published: (2010-07-01) -
Erythropoietin: from erythropoiesis to cardioprotection
by: Liermis Michael Dita Salabert, et al.
Published: (2010-08-01)